BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30588655)

  • 1. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
    Veija T; Kero M; Koljonen V; Böhling T
    Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.
    Sahi H; Koljonen V; Kavola H; Haglund C; Tukiainen E; Sihto H; Böhling T
    Virchows Arch; 2012 Nov; 461(5):553-9. PubMed ID: 22976527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of terminal deoxynucleotidyl transferase and paired box gene 5 in Merkel cell carcinomas and its relation to the presence of Merkel cell polyomavirus DNA.
    Johansson B; Sahi H; Koljonen V; Böhling T
    J Cutan Pathol; 2019 Jan; 46(1):26-32. PubMed ID: 30315594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.
    Veija T; Sarhadi VK; Koljonen V; Bohling T; Knuutila S
    Cancer Genet; 2016; 209(1-2):30-5. PubMed ID: 26725423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.
    Faust H; Andersson K; Ekström J; Hortlund M; Robsahm TE; Dillner J
    Int J Cancer; 2014 Feb; 134(4):844-8. PubMed ID: 23922031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome.
    Dabner M; McClure RJ; Harvey NT; Budgeon CA; Beer TW; Amanuel B; Wood BA
    Pathology; 2014 Apr; 46(3):205-10. PubMed ID: 24614722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.
    Busam KJ; Jungbluth AA; Rekthman N; Coit D; Pulitzer M; Bini J; Arora R; Hanson NC; Tassello JA; Frosina D; Moore P; Chang Y
    Am J Surg Pathol; 2009 Sep; 33(9):1378-85. PubMed ID: 19609205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome.
    Hall BJ; Pincus LB; Yu SS; Oh DH; Wilson AR; McCalmont TH
    J Cutan Pathol; 2012 Oct; 39(10):911-7. PubMed ID: 22882157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
    Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
    Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.
    Xie H; Lee L; Caramuta S; Höög A; Browaldh N; Björnhagen V; Larsson C; Lui WO
    J Invest Dermatol; 2014 Feb; 134(2):507-517. PubMed ID: 23962809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.
    Sastre-Garau X; Peter M; Avril MF; Laude H; Couturier J; Rozenberg F; Almeida A; Boitier F; Carlotti A; Couturaud B; Dupin N
    J Pathol; 2009 May; 218(1):48-56. PubMed ID: 19291712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
    Nwogu N; Ortiz LE; Whitehouse A; Kwun HJ
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.
    Samimi M; Gardair C; Nicol JT; Arnold F; Touzé A; Coursaget P
    Semin Oncol; 2015 Apr; 42(2):347-58. PubMed ID: 25843739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
    Amber K; McLeod MP; Nouri K
    Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
    Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
    Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.
    Houben R; Shuda M; Weinkam R; Schrama D; Feng H; Chang Y; Moore PS; Becker JC
    J Virol; 2010 Jul; 84(14):7064-72. PubMed ID: 20444890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
    Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.
    Dresang LR; Guastafierro A; Arora R; Normolle D; Chang Y; Moore PS
    PLoS One; 2013; 8(11):e80543. PubMed ID: 24260412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.